Aimmune Therapeutics is a U.S. biotechnology company focused on treatments for food allergies. Its lead product, Palforzia, is an oral immunotherapy for reducing allergic…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Aimmune →Already a subscriber? Sign in
Xcout Intel tracks Aimmune continuously — this profile deepens as new filings, funding, people and hiring data arrive.